Personal information

Other IDs

SciProfiles: 3417303

Activities

Collapse all

Works (3)

Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Based upon FIO<sub>2</sub> Requirements

Microorganisms
2024-08 | Journal article
DOI: 10.3390/microorganisms12091767
Contributors: Fernando Carvalho Neuenschwander; Ofra Barnett-Griness; Stefania Piconi; Yasmin Maor; Eduardo Sprinz; NIMER ASSY; Oleg Khmelnitskiy; Nikita V. Lomakin; Boris Mikhailovich Goloshchekin; Ewelina Nahorecka et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xenografts

Cancers
2024-03 | Journal article | Author
DOI: 10.3390/cancers16051050
Contributors: Faizal Z. Asumda; Nellie Campbell; Mohamed A. Hassan; Reza Fathi; Daniella F. Vasquez Rico; Melanie Kiem; Ethan V. Vang; Yohan Kim; Xin Luo; Daniel R. O’Brien et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Recent Progress in the Development of Opaganib for the Treatment of Covid-19

Drug Design, Development and Therapy
2022-07 | Journal article
DOI: 10.2147/DDDT.S367612
Contributors: Charles D Smith; Lynn W Maines; Staci N Keller; Vered Katz Ben-Yair; Reza Fathi; Terry F Plasse; Mark L Levitt
Source: check_circle
Crossref
How many people are using ORCID?